Targeting MmpL3 for anti-tuberculosis drug development

Bolla JR
No abstract available
Keywords:

3101 Biochemistry and Cell Biology

,

31 Biological Sciences

,

Emerging Infectious Diseases

,

Tuberculosis

,

Biodefense

,

Orphan Drug

,

Infectious Diseases

,

Rare Diseases

,

2.1 Biological and endogenous factors

,

5.1 Pharmaceuticals

,

3 Good Health and Well Being

,

Antitubercular Agents

,

Bacterial Proteins

,

Biological Transport

,

Drug Development

,

Lipids

,

Membrane Transport Proteins

,

Mycolic Acids

,

Protein Conformation